Table 3.
Duration (in weeks) from diagnosis to treatment initiation for ASCC patients by SES
| SES factor or covariate | Median (IQR) | P‐value |
|---|---|---|
| Overall | 7.9 (5.9‐10.0) | |
| Primary payer | ||
| Private | 7.4 (5.0‐9.9) | .029a |
| Medicaid | 8.9 (6.9‐14.6) | |
| Medicare | 7.3 (4.9‐9.4) | |
| Race | ||
| Majority | 7.6 (5.6‐10.1) | .254 |
| Minority | 8.1 (6.9‐10.0) | |
| Income level | ||
| Low | 7.6 (6.9‐8.9) | .677 |
| Middle | 7.9 (5.8‐10.0) | |
| Upper | 7.0 (5.4‐10.0) | |
| Employment status | ||
| Employed or retired | 7.6 (6.0‐10.0) | .465 |
| Unemployed or disabled | 8.4 (5.6‐10.7) | |
| Partnership status | ||
| Partnered | 6.7 (4.6‐9.6) | .016 |
| Unpartnered | 8.0 (6.7‐11.8) | |
| Gender | ||
| Male | 8.0 (6.6‐10.8) | .289 |
| Female | 7.6 (5.0‐9.6) | |
| TN stage | ||
| T1/T2, N‐negative | 7.7 (6.7‐9.9) | .841 |
| T1/T2, N‐positive and T3/T4, N‐negative | 7.9 (5.4‐11.7) | |
| T3/T4, N‐positive | 8.9 (5.6‐10.0) | |
| HIV status | ||
| HIV‐negative | 7.6 (5.6‐9.9) | .251 |
| HIV‐positive | 8.7 (6.7‐12.5) | |
Weeks from diagnosis to treatment initiation were log‐transformed then compared using the t test and one‐way analysis of variance, with pairwise comparisons for means by payer and income.
Abbreviations: ASCC, anal squamous cell carcinoma; IQR, interquartile range; SES, socioeconomic status; TN, tumor‐node.
a
On pairwise comparison, P = .871 for private vs medicare and P = .016 for private medicaid.